Business unit autonomy and interdepartmental collaboration
First written in FY2016. 11 of 13 entries say "Restated". Latest entry: FY2025.
No other company in this theme has enough history to compare yet.
- FY2025RestatedAnnual report
「We will strengthen cross-organizational collaboration led by the International Business Office and advance overseas expansion centered on Epadel, dienogest products and the biomaterials business.」
We continue to extend our policy of strengthening business operations through cross-functional collaboration to an organizational structure centered on the International Business Office. - FY2022ReframedAnnual report
「We will harmonize and integrate four approaches: optimizing business processes and quality standards, promoting digital transformation, reforming systems and promoting facilities management, with the aim of achieving efficient organizational management and enhancing corporate value.」
Specific measures are being developed to strengthen the corporate structure by combining the autonomy of existing business units and cross-functional collaboration with business processes, DX, systems reform and facilities management. - FY2021RestatedAnnual report
「We will operate the business units for research and development, pharmaceutical sales, pharmaceutical manufacturing and healthcare by taking into account the environment specific to each business and emphasizing cross-functional collaboration in addition to independent profitability so as to improve operational efficiency.」
We continue to pursue an organizational management policy based on business unit independent profitability and cross-functional collaboration. - FY2020RestatedAnnual report
「We will operate the business units for research and development, pharmaceutical sales, pharmaceutical manufacturing and healthcare by taking into account the environment specific to each business and emphasizing cross-functional collaboration in addition to independent profitability so as to improve operational efficiency.」
We continue to pursue an organizational management policy based on business unit autonomy, independent profitability and cross-functional collaboration. - FY2019RestatedAnnual report
「We will operate the business units for pharmaceutical sales, drug discovery research, pharmaceutical manufacturing and healthcare by taking into account the environment specific to each business and emphasizing cross-functional collaboration in addition to independent profitability so as to improve operational efficiency.」
We continue to pursue an organizational management policy based on business unit autonomy, independent profitability and cross-functional collaboration. - FY2018RestatedAnnual report
「We will pursue greater selectivity and concentration in company-wide organizational management, work to advance structural reform further, and seek to improve productivity through stronger cross-functional collaboration.」
We continue to pursue a policy of improving productivity through structural reform, business unit operations and cross-functional collaboration. - FY2018-Q3RestatedAnnual report
「Against this backdrop, during the cumulative third-quarter period of the current consolidated fiscal year, our group (the Company and its consolidated subsidiaries, hereinafter the same) continued from the previous fiscal year to promote operational reforms across all areas of management, including the development of the group management structure, optimization of staffing and efforts to improve productivity across the company.」
We continue to pursue operational reforms, including the development of the group management structure, optimization of staffing and productivity improvements across the company. - FY2018-Q2RestatedAnnual report
「Against this backdrop, during the cumulative second-quarter period of the current consolidated fiscal year, our group (the Company and its consolidated subsidiaries, hereinafter the same) continued from the previous fiscal year to promote operational reforms across all areas of management, including the development of the group management structure, optimization of staffing and efforts to improve productivity across the company.」
We continue to pursue operational reforms, including the development of the group management structure, optimization of staffing and productivity improvements across the company. - FY2018-Q1RestatedAnnual report
「Against this backdrop, during the cumulative first-quarter period of the current consolidated fiscal year, our group (the Company and its consolidated subsidiaries, hereinafter the same) continued from the previous fiscal year to promote operational reforms across all areas of management, including the development of the group management structure, optimization of staffing and efforts to improve productivity across the company.」
We continue to pursue operational reforms, including the development of the group management structure, optimization of staffing and productivity improvements across the company. - FY2017-Q3RestatedAnnual report
「Against this backdrop, during the cumulative third-quarter period of the current consolidated fiscal year, our group (the Company and its consolidated subsidiaries, hereinafter the same) continued from the previous fiscal year to promote operational reforms across all areas of management, including the development of the group management structure, optimization of staffing and efforts to improve productivity across the company.」
We continue to pursue operational reforms, including the development of the group management structure, optimization of staffing and productivity improvements. - FY2017-Q2RestatedAnnual report
「Against this backdrop, during the cumulative second-quarter period of the current consolidated fiscal year, our group (the Company and its consolidated subsidiaries, hereinafter the same) continued from the previous fiscal year to promote operational reforms across all areas of management, including the development of the group management structure, optimization of staffing and efforts to improve productivity across the company.」
We continue to pursue operational reforms, including the development of the group management structure, optimization of staffing and productivity improvements. - FY2017-Q1RestatedAnnual report
「Against this backdrop, during the cumulative first-quarter period of the current consolidated fiscal year, our group (the Company and its consolidated subsidiaries, hereinafter the same) continued from the previous fiscal year to promote operational reforms across all areas of management, including the development of the group management structure, optimization of staffing and efforts to improve productivity across the company.」
We continue to pursue operational reforms, including the development of the group management structure, optimization of staffing and productivity improvements. - FY2016First statedAnnual report
「We will promote structural reform aimed at improving productivity across the company through full autonomy of the business units and cross-functional collaboration.」
It was described together with a policy of operating pharmaceutical sales, pharmaceutical manufacturing, healthcare and head-office functions as business units.